quinidine bisulfate has been researched along with flecainide in 1 studies
| Studies (quinidine bisulfate) | Trials (quinidine bisulfate) | Recent Studies (post-2010) (quinidine bisulfate) | Studies (flecainide) | Trials (flecainide) | Recent Studies (post-2010) (flecainide) |
|---|---|---|---|---|---|
| 18 | 2 | 1 | 1,881 | 229 | 490 |
| Protein | Taxonomy | quinidine bisulfate (IC50) | flecainide (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.8905 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 6.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belhassen, B; Glick, A; Viskin, S | 1 |
1 review(s) available for quinidine bisulfate and flecainide
| Article | Year |
|---|---|
Efficacy of quinidine in high-risk patients with Brugada syndrome.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cohort Studies; Death, Sudden, Cardiac; Defibrillators, Implantable; Drug Evaluation; Electric Countershock; Electrocardiography; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Prospective Studies; Quinidine; Retrospective Studies; Risk; Shal Potassium Channels; Syndrome; Ventricular Fibrillation | 2004 |